Home > Publications database > Vitamin D receptor gene polymorphisms and risk of breast cancer in Iranian women > print |
001 | 178165 | ||
005 | 20240917160649.0 | ||
024 | 7 | _ | |a 10.1016/j.amsu.2021.103150 |2 doi |
024 | 7 | _ | |a altmetric:128213711 |2 altmetric |
024 | 7 | _ | |a pmid:34917354 |2 pmid |
037 | _ | _ | |a DKFZ-2021-03170 |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Kazemi, Seyedeh Maryam |0 P:(DE-He78)d898499897bb4b2d69b7abe0f84851c3 |b 0 |e First author |u dkfz |
245 | _ | _ | |a Vitamin D receptor gene polymorphisms and risk of breast cancer in Iranian women |
260 | _ | _ | |a Amsterdam [u.a.] |c 2022 |b Elsevier |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1726581982_21166 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
500 | _ | _ | |a #EA:G401# |
536 | _ | _ | |a 311 - Zellbiologie und Tumorbiologie (POF4-311) |0 G:(DE-HGF)POF4-311 |c POF4-311 |f POF IV |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, Journals: inrepo01.inet.dkfz-heidelberg.de |
700 | 1 | _ | |a Esmaieli-bandboni, Aghil |b 1 |
700 | 1 | _ | |a Veisi Malekshahi, Ziba |b 2 |
700 | 1 | _ | |a Shahbaz Sardood, Mohammad |b 3 |
700 | 1 | _ | |a Hashemi, Mehrdad |b 4 |
700 | 1 | _ | |a Majidzadeh, Keivan |b 5 |
700 | 1 | _ | |a Kadkhodazadeh, Maryam |b 6 |
700 | 1 | _ | |a Esmaili, Rezvan |b 7 |
700 | 1 | _ | |a Negahdari, Babak |b 8 |
773 | _ | _ | |a 10.1016/j.amsu.2021.103150 |g Vol. 73, p. 103150 - |0 PERI:(DE-600)2745440-X |p 103150 |t Annals of medicine and surgery |v 73 |y 2022 |x 2049-0801 |
909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:178165 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 P:(DE-He78)d898499897bb4b2d69b7abe0f84851c3 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-311 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Zellbiologie und Tumorbiologie |x 0 |
914 | 1 | _ | |y 2022 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2022-11-12 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2022-11-12 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2022-11-12 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0112 |2 StatID |b Emerging Sources Citation Index |d 2022-11-12 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2022-11-12 |
920 | 1 | _ | |0 I:(DE-He78)G401-20160331 |k G401 |l Molekulare Toxikologie und Chemotherapie |x 0 |
920 | 0 | _ | |0 I:(DE-He78)G401-20160331 |k G401 |l Molekulare Toxikologie und Chemotherapie |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)G401-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|